ADAPTIMMUNE THERAPEUTICS PLC Proceeds from Common Stock Issued
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Proceeds from Common Stock Issued of $1.77 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-08-13
- ADAPTIMMUNE THERAPEUTICS PLC proceeds from issuance of common stock for the quarter ending 2025-06-30 was $1.65M, a 16430.00% increase year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC proceeds from issuance of common stock for the quarter ending 2025-03-31 was $122.00K, a 99.58% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC proceeds from issuance of common stock for the quarter ending 2024-12-31 was $1.00K, a 0.00% change year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC proceeds from issuance of common stock for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC proceeds from issuance of common stock for fiscal 2024 was $29.17M, a 4575.00% increase from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC proceeds from issuance of common stock for fiscal 2023 was $624.00K, a 95.13% decline from fiscal 2022.
- ADAPTIMMUNE THERAPEUTICS PLC proceeds from issuance of common stock for fiscal 2022 was $12.82M, a 406.80% increase from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC proceeds from issuance of common stock for fiscal 2021 was $2.53M, a 99.24% decline from fiscal 2020.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2025-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.77M 10-Q · filed 2025-08-13 | $1.78M derived: sum of 3 quarters · filed 2025-08-13 | $1.78M derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | $122.00K 10-Q · filed 2025-05-13 | $123.00K derived: sum of 2 quarters · filed 2025-05-13 | $123.00K derived: sum of 3 quarters · filed 2025-05-13 | $133.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.00K derived: sum of 2 quarters · filed 2025-03-24 | $11.00K derived: sum of 3 quarters · filed 2025-08-13 | $29.17M 10-K · filed 2025-03-24 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $10.00K derived: sum of 2 quarters · filed 2025-08-13 | $29.17M 10-Q · filed 2024-11-13 | $29.17M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $29.17M 10-Q · filed 2025-08-13 | $29.17M derived: sum of 3 quarters · filed 2025-08-13 | $29.61M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $29.16M 10-Q · filed 2025-05-13 | $29.16M derived: sum of 2 quarters · filed 2025-05-13 | $29.60M derived: sum of 3 quarters · filed 2025-05-13 | $29.60M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $436.00K derived: sum of 2 quarters · filed 2025-03-24 | $436.00K derived: sum of 3 quarters · filed 2025-03-24 | $624.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $435.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $435.00K derived: sum of 2 quarters · filed 2024-11-13 | $623.00K 10-Q · filed 2024-11-13 | $2.02M derived: sum of 4 quarters · filed 2025-03-24 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $188.00K 10-Q · filed 2024-08-12 | $1.58M derived: sum of 3 quarters · filed 2025-03-24 | $3.03M derived: sum of 4 quarters · filed 2025-03-24 |
| 2023-03-31 | $188.00K 10-Q · filed 2024-05-15 | $1.58M derived: sum of 2 quarters · filed 2025-03-24 | $3.03M derived: sum of 3 quarters · filed 2025-03-24 | |
| 2022-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $2.84M derived: sum of 2 quarters · filed 2025-03-24 | $12.82M 10-K · filed 2025-03-24 | |
| 2022-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $11.42M 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $9.98M 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $10.00K derived: sum of 2 quarters · filed 2024-03-06 | $2.53M 10-K · filed 2024-03-06 | |
| 2021-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.53M 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $2.52M 10-Q · filed 2022-08-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $243.84M derived: sum of 3 quarters · filed 2023-03-06 | $334.39M 10-K · filed 2023-03-06 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $243.84M derived: sum of 2 quarters · filed 2021-11-04 | $334.39M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $243.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $334.39M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $90.55M 10-Q · filed 2021-05-06 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $99.65M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $99.65M 10-Q · filed 2019-11-06 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $41.77M derived: sum of 3 quarters · filed 2019-02-27 | $103.17M 10-K · filed 2019-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $41.77M derived: sum of 2 quarters · filed 2018-11-06 | $103.17M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $41.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $103.17M 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $61.40M 10-Q · filed 2018-05-09 | |||
| 2014-06-30 | $15.81M 10-K · filed 2017-03-13 | |||
| 2013-06-30 | $6.60M 8-K · filed 2016-07-08 |